Company Filing History:
2 out of 234 
1 out of 3,699 
1 out of 106 Years Active: 2001-2007
Title: Innovations and Contributions of Inventor Xiaohua He
Introduction
Xiaohua He is a notable inventor based in Hockessin, Delaware, who has made significant contributions to the field of pharmaceutical sciences. With a total of five patents to her name, she has focused on developing innovative compounds that serve as inhibitors for various enzymes.
Latest Patents
Her latest patents include the invention of substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives. These compounds are designed as inhibitors of matrix metalloproteinases and TNF-α converting enzyme (TACE). The invention describes novel compounds that are useful as selective inhibitors of MMP, TACE, aggrecanase, or a combination thereof. Additionally, she has developed cyclic hydroxamic acids that serve as metalloprotease inhibitors, showcasing her expertise in creating pharmaceutical compositions with significant therapeutic potential.
Career Highlights
Xiaohua He has worked with Bristol-Myers Squibb Pharma Company, where she has contributed to various research projects and innovations. Her work in the pharmaceutical industry has been instrumental in advancing the development of new therapeutic agents.
Collaborations
Throughout her career, Xiaohua has collaborated with notable professionals, including Carl P. Decicco and Chu-Biao Xue. These collaborations have further enriched her research and development efforts.
Conclusion
Xiaohua He is a distinguished inventor whose work in pharmaceutical innovations has led to the development of important compounds with potential therapeutic applications. Her contributions continue to impact the field positively.